Legend Biotech Corp
NASDAQ:LEGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Legend Biotech Corp
NASDAQ:LEGN
|
US |
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
|
V
|
Verimatrix SA
OTC:ISDCF
|
FR |
|
Haitian International Holdings Ltd
HKEX:1882
|
CN |
|
E2 Metals Ltd
ASX:E2M
|
AU |
|
Japan Steel Works Ltd
OTC:JPSWY
|
JP |
|
Sungshin Cement Co Ltd
KRX:004980
|
KR |
|
J
|
Joong Ang Enervis Co Ltd
KOSDAQ:000440
|
KR |
Shareholder Yield
Current shareholder yield for LEGN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LEGN Price
Legend Biotech Corp
| Average Annual Return | 16.63% |
| Standard Deviation of Annual Returns | 52.69% |
| Max Drawdown | -78% |
| Market Capitalization | 3.8B USD |
| Shares Outstanding | 183 450 500 |
| Percentage of Shares Shorted | 20.74% |
